- Report
- June 2026
- 352 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 190 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- May 2026
- 185 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- January 2026
- 191 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- May 2026
- 182 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- May 2026
- 189 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- May 2026
- 180 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- May 2026
- 185 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- May 2026
- 185 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- January 2026
- 180 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- January 2026
- 185 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- July 2025
- 350 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- July 2025
- 350 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- July 2025
- 350 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- July 2025
- 350 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2026
- 135 Pages
Global
From €3622EUR$3,999USD£3,125GBP
- Report
- April 2026
- 145 Pages
Global
From €3622EUR$3,999USD£3,125GBP
- Report
- April 2026
- 148 Pages
Global
From €3622EUR$3,999USD£3,125GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva 91¿´Æ¬. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more